Telix
Telix Pharmaceuticals, established in 2018 and headquartered in North Melbourne, Australia, is a radiopharmaceutical company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the United States.
Last updated on
About Telix
Founded
2017Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$25MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
62151Location
City
North MelbourneState
VictoriaCountry
AustraliaTech Stack (77)
